Vista Pharmaceuticals informs about outcome of AGM

27 Sep 2021 Evaluate

Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Vista Pharmaceuticals has informed that the members of the Company have approved all the resolutions bearing item no. 1 & 2 contained in the Notice of 29th Annual General Meeting of the Company with requisite majority. The Company had appointed NVSS Suryanarayana Rao, Company Secretary in practice as the Scrutinizer for remote e-voting and venue e-voting at the AGM. The Scrutinizer has submitted his report on 27th September, 2021. In this connection, the company has enclosed the consolidated results of the remote e-voting and venue e-voting at the Video Conferencing (VC) / Other Audio-Visual Means (OAVM) meeting in the format prescribed together with the Scrutinizer’s Report. On the basis of the report received from the Scrutinizer, the Company has declared that the Resolutions set out in the notice of 29th AGM were passed with requisite majority in favour of the Resolutions.

The above information is a part of company’s filings submitted to BSE.

Vista Pharma Share Price

11.30 0.37 (3.39%)
17-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1751.05
Dr. Reddys Lab 1163.70
Cipla 1515.45
Lupin 1936.75
Zydus Lifesciences 831.40
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...